US Patent Number
Disclosed herein are methods for detecting Pgrmc 1 in bodily fluids, e.g., blood, plasma and serum, wherein detection of Pgrmcl is a biomarker for the presence of cancer, e.g., lung cancer or head or neck cancer. Pgrmc 1 levels in bodily fluids may be used to predict patient prognosis, e.g., survival and response to therapy.
University of Kentucky Research Foundation, Lexington, KY, (US)
Craven, Rolf Joseph, "Secreted Tumor-Associated Cytochrome as a Blood-Based Biomarker for Cancer" (2019). Pharmacology and Nutritional Sciences Faculty Patents. 53.